Jonathan Ameen Jalali, MD
NPI 1548840929ActiveIndividual· Internal Medicine, Allergy & Immunology· Pasadena, CA
Internal Medicine, Allergy & Immunology (MD) in Pasadena, California, trained at University of Missouri, Kansas City, School of Medicine (class of 2021). Part D covered 95 prescriptions written in 2024, 91% of them generic. Biocryst Pharmaceuticals, Inc. was the largest of 5 companies reporting payments in 2025, $572.51 in all, mostly food and beverage.
Overview
| NPI | 1548840929 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Apr 10, 2021 |
| Last updated in NPPES | Aug 3, 2026 |
| Certified by provider | Aug 3, 2026 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Allergy & Immunology Primary | 207RA0201X | A195416 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Internal Medicine (CA) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 95 · 221 30-day fills |
|---|---|
| Patients | 14 |
| Total drug cost | $13,790 |
| Generic share | 91% of claims |
Education and affiliations
| Medical school | University of Missouri, Kansas City, School of Medicine |
|---|---|
| Graduation year | 2021 |
| Medicare specialty | Internal Medicine |
| Secondary specialties | Allergy/Immunology |
Medical group
- The Regents of the University of CaliforniaSanta Monica, CA · 1,462 clinicians
Industry payments (Open Payments)
- 2025$572.51 · 5 payments from 5 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Biocryst Pharmaceuticals, Inc. | $150.80 | 1 |
| Biocryst US Sales Co., LLC | $149.97 | 1 |
| Glaxosmithkline, LLC. | $121.08 | 1 |
| Regeneron Healthcare Solutions, Inc. | $120.17 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $30.49 | 1 |
What the 2025 payments were for
- Food and Beverage$572.51 · 5 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records